Nifuroxazide
- Generic Name
- Nifuroxazide
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C12H9N3O5
- CAS Number
- 965-52-6
- Unique Ingredient Identifier
- PM5LI0P38J
- Associated Conditions
- Acute Diarrhea, Amebiasis, Colitis, Giardiasis, Liver Abscess, Amebic, Trichomonas Vaginitis
- Associated Therapies
- -
Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis
Phase 2
Recruiting
- Conditions
- Inflammatory Bowel Diseases
- Interventions
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Mostafa Bahaa
- Target Recruit Count
- 50
- Registration Number
- NCT05988528
- Locations
- ๐ช๐ฌ
Tanta University, Tanta, Egypt
Efficacy and Safety of Nifuroxazide in the Treatment of Hepatic Encephalopathy in Egyptian Patients With Liver Cirrhosis
Phase 3
Recruiting
- Conditions
- Hepatic Encephalopathy
- Interventions
- First Posted Date
- 2023-03-06
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- Cairo University
- Target Recruit Count
- 102
- Registration Number
- NCT05754996
- Locations
- ๐ช๐ฌ
National Hepatology and Tropical Medicine Research Institute (NHTMRI), Cairo, Egypt
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2025. All Rights Reserved by MedPath